CIK 0001857044 · Non-accelerated filer<br>Smaller reporting company
Indaptus Therapeutics, Inc.
Sign in to watch- Ticker
- INDP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863158720
- Phone
- (646) 427-2727
- Business address
- 3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK, NY, 10019
- Former names
- Intec Parent Inc.
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- SC 13D Stake Beneficial Ownership Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- D/A Other Amended Notice of Exempt Offering of Securities
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- D Other Notice of Sales of Unregistered Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Grant or award CEO and Director acquired 84,932 shares (grant or award)
Page 8 of 18 · 343 filings